Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baraldi

Showing results (1151-1160 of 1,515) with videos related to

Pageof 152
Sort By:
Anti-Cancer Drug Design|November 20, 1997
Synthesis, cytotoxicity, antitumor activity and sequence selective binding of two pyrazole analogs structurally related to the antitumor agents U-71,184 and adozelesinP G Baraldi, B Cacciari, R Romagnoli, et al.
Scandinavian Journal of Gastroenterology|April 21, 1998
Benzodiazepine-like compounds in the plasma of patients with fulminant hepatic failureM L Zeneroli, I Venturini, L Corsi, et al.
Journal of Medicinal Chemistry|September 19, 2003
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigationGiorgia Pastorin, Tatiana Da Ros, Giampiero Spalluto, et al.
Physiologia Plantarum|January 6, 2022
Exposure to different light intensities affects emission of volatiles and accumulations of both pigments and phenolics in Azolla filiculoidesFederico Brilli, K G Srikanta Dani, Stefania Pasqualini, et al.
European Journal of Medicinal Chemistry|May 27, 2014
Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Schizophrenia Research|June 8, 2011
Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcomeCatherine L Clelland, Laura L Read, Amanda N Baraldi, et al.
European Journal of Medicinal Chemistry|July 8, 2010
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptorsSilvia Franchini, Adolfo Prandi, Annamaria Baraldi, et al.
Journal of Medicinal Chemistry|February 2, 1996
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptorsP G Baraldi, B Cacciari, G Spalluto, et al.
Global & Regional Health Technology Assessment|February 3, 2025
Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in ItalyAndrea Marcellusi, Chiara Bini, Barbara Muzii, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
Successful Control of an Outbreak by Phenotypically Identified Extended-Spectrum Beta-Lactamase-Producing <i>Klebsiella pneumoniae</i> in a Neonatal Intensive Care UnitElena Priante, Chiara Minotti, Cristina Contessa, et al.
Pageof 152

Showing results (1151-1160 of 1,515) with videos related to

Sort By:
Pageof 152
Anti-Cancer Drug Design|November 20, 1997
Synthesis, cytotoxicity, antitumor activity and sequence selective binding of two pyrazole analogs structurally related to the antitumor agents U-71,184 and adozelesinP G Baraldi, B Cacciari, R Romagnoli, et al.
Scandinavian Journal of Gastroenterology|April 21, 1998
Benzodiazepine-like compounds in the plasma of patients with fulminant hepatic failureM L Zeneroli, I Venturini, L Corsi, et al.
Journal of Medicinal Chemistry|September 19, 2003
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigationGiorgia Pastorin, Tatiana Da Ros, Giampiero Spalluto, et al.
Physiologia Plantarum|January 6, 2022
Exposure to different light intensities affects emission of volatiles and accumulations of both pigments and phenolics in Azolla filiculoidesFederico Brilli, K G Srikanta Dani, Stefania Pasqualini, et al.
European Journal of Medicinal Chemistry|May 27, 2014
Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agentsRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Schizophrenia Research|June 8, 2011
Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcomeCatherine L Clelland, Laura L Read, Amanda N Baraldi, et al.
European Journal of Medicinal Chemistry|July 8, 2010
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptorsSilvia Franchini, Adolfo Prandi, Annamaria Baraldi, et al.
Journal of Medicinal Chemistry|February 2, 1996
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptorsP G Baraldi, B Cacciari, G Spalluto, et al.
Global & Regional Health Technology Assessment|February 3, 2025
Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in ItalyAndrea Marcellusi, Chiara Bini, Barbara Muzii, et al.
Antibiotics (Basel, Switzerland)|November 24, 2022
Successful Control of an Outbreak by Phenotypically Identified Extended-Spectrum Beta-Lactamase-Producing <i>Klebsiella pneumoniae</i> in a Neonatal Intensive Care UnitElena Priante, Chiara Minotti, Cristina Contessa, et al.
Pageof 152